phosphatidylcholines has been researched along with atorvastatin in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (atorvastatin) | Trials (atorvastatin) | Recent Studies (post-2010) (atorvastatin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 7,420 | 2,058 | 3,782 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | atorvastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0064 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0002 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0002 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0054 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arishima, H; Katafuchi, R; Matsunaga, A; Rye, KA; Saku, K; Zhang, B | 1 |
| Ma, X; Wang, F; Wang, M; Wang, Y; Zhao, C; Zhao, M | 1 |
2 other study(ies) available for phosphatidylcholines and atorvastatin
| Article | Year |
|---|---|
Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis.
Topics: Adult; Apolipoprotein A-I; Apolipoprotein E2; Atorvastatin; Electrophoresis, Capillary; Heptanoic Acids; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Macromolecular Substances; Male; Phenotype; Phosphatidylcholines; Pyrroles; Sensitivity and Specificity; Time Factors; Triglycerides | 2006 |
Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Gynostemma; Heptanoic Acids; Hyperlipidemias; Lipid Metabolism; Liver; Magnetic Resonance Spectroscopy; Male; Metabolomics; Methylamines; Phosphatidylcholines; Phytotherapy; Plant Extracts; Pyrroles; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triglycerides | 2013 |